Copyright Reports & Markets. All rights reserved.

Global Impetigo Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Impetigo Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Cephalosporins
      • 1.4.3 Fusidane
      • 1.4.4 Lincosamide Antibiotic
      • 1.4.5 Penicillin
      • 1.4.6 Penicillin-Like Antibiotics
      • 1.4.7 Pleuromutilin
      • 1.4.8 Pseudomonic Acid A
      • 1.4.9 Quinolone
      • 1.4.10 Sulfonamides And Folic Acid Inhibitors
      • 1.4.11 Tetracyclines
    • 1.5 Market by Application
      • 1.5.1 Global Impetigo Treatment Market Share by Application (2019-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinic
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Impetigo Treatment Market Size
    • 2.2 Impetigo Treatment Growth Trends by Regions
      • 2.2.1 Impetigo Treatment Market Size by Regions (2019-2025)
      • 2.2.2 Impetigo Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Impetigo Treatment Market Size by by Players
      • 3.1.1 Global Impetigo Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Impetigo Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Impetigo Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Impetigo Treatment Key Players Head office and Area Served
    • 3.3 Key Players Impetigo Treatment Product/Solution/Service
    • 3.4 Date of Enter into Impetigo Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Impetigo Treatment Market Size by Type (2014-2019)
    • 4.2 Global Impetigo Treatment Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Impetigo Treatment Market Size (2014-2019)
    • 5.2 Impetigo Treatment Key Players in North America
    • 5.3 North America Impetigo Treatment Market Size by Type
    • 5.4 North America Impetigo Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Impetigo Treatment Market Size (2014-2019)
    • 6.2 Impetigo Treatment Key Players in Europe
    • 6.3 Europe Impetigo Treatment Market Size by Type
    • 6.4 Europe Impetigo Treatment Market Size by Application

    7 China

    • 7.1 China Impetigo Treatment Market Size (2014-2019)
    • 7.2 Impetigo Treatment Key Players in China
    • 7.3 China Impetigo Treatment Market Size by Type
    • 7.4 China Impetigo Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Impetigo Treatment Market Size (2014-2019)
    • 8.2 Impetigo Treatment Key Players in Japan
    • 8.3 Japan Impetigo Treatment Market Size by Type
    • 8.4 Japan Impetigo Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Impetigo Treatment Market Size (2014-2019)
    • 9.2 Impetigo Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Impetigo Treatment Market Size by Type
    • 9.4 Southeast Asia Impetigo Treatment Market Size by Application

    10 India

    • 10.1 India Impetigo Treatment Market Size (2014-2019)
    • 10.2 Impetigo Treatment Key Players in India
    • 10.3 India Impetigo Treatment Market Size by Type
    • 10.4 India Impetigo Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Impetigo Treatment Market Size (2014-2019)
    • 11.2 Impetigo Treatment Key Players in Central & South America
    • 11.3 Central & South America Impetigo Treatment Market Size by Type
    • 11.4 Central & South America Impetigo Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 GlaxoSmithKline plc
      • 12.1.1 GlaxoSmithKline plc Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Impetigo Treatment Introduction
      • 12.1.4 GlaxoSmithKline plc Revenue in Impetigo Treatment Business (2014-2019))
      • 12.1.5 GlaxoSmithKline plc Recent Development
    • 12.2 Karalex Pharma, LLC
      • 12.2.1 Karalex Pharma, LLC Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Impetigo Treatment Introduction
      • 12.2.4 Karalex Pharma, LLC Revenue in Impetigo Treatment Business (2014-2019)
      • 12.2.5 Karalex Pharma, LLC Recent Development
    • 12.3 Leo Pharma A/S
      • 12.3.1 Leo Pharma A/S Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Impetigo Treatment Introduction
      • 12.3.4 Leo Pharma A/S Revenue in Impetigo Treatment Business (2014-2019)
      • 12.3.5 Leo Pharma A/S Recent Development
    • 12.4 Lupin Limited
      • 12.4.1 Lupin Limited Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Impetigo Treatment Introduction
      • 12.4.4 Lupin Limited Revenue in Impetigo Treatment Business (2014-2019)
      • 12.4.5 Lupin Limited Recent Development
    • 12.5 NovaBay Pharmaceuticals, Inc.
      • 12.5.1 NovaBay Pharmaceuticals, Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Impetigo Treatment Introduction
      • 12.5.4 NovaBay Pharmaceuticals, Inc. Revenue in Impetigo Treatment Business (2014-2019)
      • 12.5.5 NovaBay Pharmaceuticals, Inc. Recent Development
    • 12.6 Pfizer, Inc.
      • 12.6.1 Pfizer, Inc. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Impetigo Treatment Introduction
      • 12.6.4 Pfizer, Inc. Revenue in Impetigo Treatment Business (2014-2019)
      • 12.6.5 Pfizer, Inc. Recent Development
    • 12.7 Ranbaxy Laboratories Limited
      • 12.7.1 Ranbaxy Laboratories Limited Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Impetigo Treatment Introduction
      • 12.7.4 Ranbaxy Laboratories Limited Revenue in Impetigo Treatment Business (2014-2019)
      • 12.7.5 Ranbaxy Laboratories Limited Recent Development
    • 12.8 Roche Holding AG
      • 12.8.1 Roche Holding AG Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Impetigo Treatment Introduction
      • 12.8.4 Roche Holding AG Revenue in Impetigo Treatment Business (2014-2019)
      • 12.8.5 Roche Holding AG Recent Development
    • 12.9 SANDOZ GmbH
      • 12.9.1 SANDOZ GmbH Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Impetigo Treatment Introduction
      • 12.9.4 SANDOZ GmbH Revenue in Impetigo Treatment Business (2014-2019)
      • 12.9.5 SANDOZ GmbH Recent Development
    • 12.10 Taro Pharmaceutical Industries Ltd
      • 12.10.1 Taro Pharmaceutical Industries Ltd Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Impetigo Treatment Introduction
      • 12.10.4 Taro Pharmaceutical Industries Ltd Revenue in Impetigo Treatment Business (2014-2019)
      • 12.10.5 Taro Pharmaceutical Industries Ltd Recent Development
    • 12.11 Teva Pharmaceutical Industries Ltd

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Impetigo Treatment is typically treated with an antibiotic ointment or cream that apply directly to the sores.
      In 2018, the global Impetigo Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Impetigo Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Impetigo Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      GlaxoSmithKline plc
      Karalex Pharma, LLC
      Leo Pharma A/S
      Lupin Limited
      NovaBay Pharmaceuticals, Inc.
      Pfizer, Inc.
      Ranbaxy Laboratories Limited
      Roche Holding AG
      SANDOZ GmbH
      Taro Pharmaceutical Industries Ltd
      Teva Pharmaceutical Industries Ltd

      Market segment by Type, the product can be split into
      Cephalosporins
      Fusidane
      Lincosamide Antibiotic
      Penicillin
      Penicillin-Like Antibiotics
      Pleuromutilin
      Pseudomonic Acid A
      Quinolone
      Sulfonamides And Folic Acid Inhibitors
      Tetracyclines

      Market segment by Application, split into
      Hospitals
      Clinic
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Impetigo Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Impetigo Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Impetigo Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now